New Data Analyses On CONCERTA® Pediatric Treatment Include Insight On Handwriting Performance And Attention In ADHD
Data presented at a major medical meeting include findings that demonstrate improved handwriting performance in children with Attention Deficit Hyperactivity Disorder (ADHD) when taking CONCERTA® (OROS® methylphenidate HCl Extended-Release Tablets CII) compared to placebo. This data, which was presented by McNeil Pediatrics™, Division of Ortho-McNeil-Janssen
订阅：
博文评论 (Atom)
没有评论:
发表评论